IAD Index of Academic Documents
  • Home Page
  • About
    • About Izmir Academy Association
    • About IAD Index
    • IAD Team
    • IAD Logos and Links
    • Policies
    • Contact
  • Submit A Journal
  • Submit A Conference
  • Submit Paper/Book
    • Submit a Preprint
    • Submit a Book
  • Contact
  • Journal of Experimental and Clinical Medicine
  • Volume:41 Issue:1
  • The effect of vitamin D supplementation on bone mineral density in patients with differentiated thyr...

The effect of vitamin D supplementation on bone mineral density in patients with differentiated thyroid cancer

Authors : Ebru Yılmaz, Güzin Töre
Pages : 1-8
View : 164 | Download : 102
Publication Date : 2024-03-29
Article Type : Research Paper
Abstract :It has demonstrated that there is a connection between chronic TSH suppressive treatment and the reduction of bone mineral density (BMD) or the development of osteoporosis in patients with differentiated thyroid cancer (DTC). The aim of the study was to determine the effect of vitamin D3 supplementation on BMD and the development of osteoporosis in patients with DTC. Two hundred four (204) patients with a diagnosis of DTC were included. All patients received thyroid hormone replacement therapy along with vitamin D (5000IU/day). Data including age, gender, body mass index, smoking, menopausal status, family history of osteoporosis, and postoperative duration were collected. The serum levels of TSH, calcium, 25-OH-vitamin D, and parathyroid hormone measurements and BMD by using dual-energy X-ray absorptiometry were performed on whole patients. The mean age of patients was 56.20±9.31 years. With osteoporosis, 22 of the patients were female (10.8%) and 1 was male (0.5%). Twenty one (21) females with OP were postmenopausal state. There was a statistically significant difference between osteoporosis and age, menopausal status, and family history of osteoporosis, but not for the other factors. Although there was no statistically significant difference between osteoporosis and the levels of TSH and vitamin D, most patients with osteoporosis had TSH<0.5 mIU/mL (n=18) and vitamin D<30 ng/mL (n=16). Age and family history of osteoporosis were identified as independent predictive factors for developing osteoporosis. Vitamin D may be considered as a supplemental and supportive treatment in patients with thyroid cancer for preventing cancer recurrence and osteoporosis.
Keywords : Differentiated thyroid cancer, TSH suppressive therapy, osteoporosis, vitamin D

ORIGINAL ARTICLE URL

* There may have been changes in the journal, article,conference, book, preprint etc. informations. Therefore, it would be appropriate to follow the information on the official page of the source. The information here is shared for informational purposes. IAD is not responsible for incorrect or missing information.


Index of Academic Documents
İzmir Academy Association
CopyRight © 2023-2026